ADAC
LIVE

Serial Number

79322105

Owner

Strike Pharma AB

Attorney

Donna J. Bunton

Filing Date

Aug 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ADAC Trademark

Serial Number: 79322105 • Registration: 6970291

ADAC is a trademark filed by Strike Pharma AB on August 24, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Strike Pharma AB (3 trademarks)

Ulls väg 29C

Entity Type: 09

Trademark Details

Filing Date

August 24, 2021

Registration Date

February 7, 2023

Published for Opposition

November 22, 2022

Goods & Services

Chemicals for use in industry for production of antibodies and synthetic and natural peptides

Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies

Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes

Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Apr 16, 2026 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 8, 2023 FICS
FINAL DISPOSITION PROCESSED
May 8, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 7, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2022 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2022 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 25, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 25, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 25, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 25, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2022 TROA
REFUSAL PROCESSED BY IB
Apr 11, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 18, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 18, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 17, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 16, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2022 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2021 ADCH
APPLICATION FILING RECEIPT MAILED
Oct 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 8, 2021 REPR